|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Molecular Genetics |
Departments of Pathology (R.N.W., B.K.A.R., H.S.F., S.H.B.), Surgery (H.S.F., A.H.F.), and Pediatrics (H.S.F.), Duke University, Durham, NC 27710
1 Address correspondence and reprint requests to Sandra H. Bigner, Duke University Medical Center, Department of Pathology, PO Box 3712, Durham, NC 27710.
Abstract
Cytogenetic and molecular genetic studies of glioblastoma multiforme (GBM) have shown that the most frequent alterations are gains of chromosome 7, losses of 9p loci and chromosome 10, and gene amplification, primarily of the epidermal growth factor receptor (EGFR) gene. Although this profile is potentially useful in distinguishing GBM from other tumor types, the techniques used tend to be labor intensive, and some can detect only gains or losses of genetic loci. Comparative genomic hybridization (CGH) is a powerful technique capable of identifying both gains and losses of DNA sequences. The present study compares the CGH evaluation of 22 GBM with classic cytogenetics, loss of heterozygosity by allelotyping, and gene amplification by Southern blot analysis to determine the reliability of CGH in the genetic characterization of GBM. The CGH and karyotypic data were consistent in showing gain of chromosome 7 accompanied by a loss of chromosome 10 as the most frequent abnormality, followed by a loss of 9p in 17 of 22 GBM cases. Loss of heterozygosity of chromosomes 10 (19/22) and 9p (9/22) loci confirmed the underrepresentation by CGH. Genomic amplifications were observed by CGH in 5 of the 10 cases where gene amplification was detected by Southern blot analysis. The data show that CGH is equally reliable, compared with the more established genetic methods, for recognizing the prominent genetic alterations associated with GBM and support its use as a plausible adjunct to glioma classification.
References
Bello, M.J., de Campos, J.M., Vaquero, J., Kusak, M.E., Sarasa, J.L., Pestana, A., and Rey, J.A. (1994) Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosomes Cancer 9,33 -41.[Web of Science][Medline]
Bentz, M., Dohner, H., Huck, K., Schutz, B., Ganser, A., Joos, S., du Manoir, S., and Lichter, P. (1995) Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer 12,193 -200.[Web of Science][Medline]
Bigner, D.D., McLendon, R.E., and Bruner, J.M. (Eds.) (1998) Russell and Rubinstein's Pathology of Tumors of the Nervous System. London: Arnold.
Bigner, S.H., Wong, A.J., Mark, J., Muhlbaier, L.H., Kinzler, K.W., Vogelstein, B., and Bigner, D.D. (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet. Cytogenet. 29,165 -170.[CrossRef][Web of Science][Medline]
Bigner, S.H., Mark, J., Burger, P.C., Mahaley, M.S., Jr., Bullard,
D.E., Muhlbaier, L.H., and Bigner, D.D. (1988a) Specific
chromosomal abnormalities in malignant human gliomas. Cancer
Res. 48,405
-411.
Bigner, S.H., Burger, P.C., Wong, A.J., Werner, M.H., Hamilton, S.R., Muhlbaier, L.H., Vogelstein, B., and Bigner, D.D. (1988b) Gene amplification in malignant human gliomas: Clinical and histopathologic aspects. J. Neuropathol. Exp. Neurol. 47,191 -205.[Web of Science][Medline]
Bigner, S.H., Mark, J., and Bigner, D.D. (1990) Cytogenetics of human brain tumors. Cancer Genet. Cytogenet. 47,141 -154.[CrossRef][Web of Science][Medline]
Bigner, S.H., Matthews, M.R., Rasheed, B.K.A., Wiltshire, R.N.,
Friedman, H.S., Friedman, A.H., Stenzel, T.T., Dawes, D.M., McLendon, R.E.,
and Bigner, D.D. (1999) Molecular genetic aspects of
oligodendrogliomas including analysis by comparative genomic hybridization.
Am. J. Pathol. 155,375
-386.
Blaeker, H., Rasheed, B.K., McLendon, R.E., Friedman, H.S., Batra, S.K., Fuchs, H.E., and Bigner, S.H. (1996) Microsatellite analysis of childhood brain tumors. Genes Chromosomes Cancer 15,54 -63.[CrossRef][Web of Science][Medline]
Collins, V.P. (1995a) Gene amplification in human gliomas. Glia 15,289 -296.[CrossRef][Web of Science][Medline]
Collins, V.P. (1995b) Genetic alterations in gliomas. J. Neurooncol. 24,37 -38.[CrossRef][Medline]
Debiec-Rychter, M., Alwasiak, J., Liberski, P.P., Nedoszytko, B., Babinska, M., Mrozek, K., Imielinski, B., Borowska-Lehman, J., and Limon, J. (1995) Accumulation of chromosomal changes in human glioma progression: A cytogenetic study of 50 cases. Cancer Genet. Cytogenet. 85,61 -67.[CrossRef][Web of Science][Medline]
Fischer, U., Wullich, B., Sattler, H.P., Gottert, E., Zang, K.D., and Meese, E. (1994) DNA amplifications on chromosomes 7, 9 and 12 in glioblastoma detected by reverse chromosome painting. Eur. J. Cancer 30A,1124 -1127.[CrossRef]
Fults, D., Pedone, C.A., Thomas, G.A., and White, R.
(1990) Allelotype of human malignant astrocytoma.
Cancer Res. 50,5784
-5789.
Giani, C., and Finocchiaro, G. (1994) Mutation rate of
the CDKN2 gene in malignant gliomas. Cancer Res.
54,6338
-6339.
Giollant, M., Bertrand, S., Verrelle, P., Tchirkov, A., du Manoir, S., Ried, T., Mornex, F., Dore, J.F., Cremer, T., and Malet, P. (1996) Characterization of double minute chromosomes' DNA content in a human high grade astrocytoma cell line by using comparative genomic hybridization and fluorescence in situ hybridization. Hum. Genet. 98,265 -270.[CrossRef][Web of Science][Medline]
Gribble, S.M., Sinclair, P.B., Grace, C., Green, A.R., and Nacheva, E.P. (1999) Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis. Cancer Genet. Cytogenet. 111, 7-17.[CrossRef][Web of Science][Medline]
He, J., Allen, J.R., Collins, V.P., Allalunis-Turner, M.J.,
Godbout, R., Day, R.S., III, and James, C.D. (1994) CDK4
amplification is an alternative mechanism to p16 gene homozygous deletion in
glioma cell lines. Cancer Res.
54,5804
-5807.
James, C.D., Carlbom, E., Dumanski, J.P., Hansen, M., Nordenskjold,
M., Collins, V.P., and Cavenee, W.K. (1988) Clonal genomic
alterations in glioma malignancy stages. Cancer Res.
48,5546
-5551.
Jen, J., Harper, J.W., Bigner, S.H., Bigner, D.D., Papadopoulos,
N., Markowitz, S., Willson, J.K., Kinzler, K.W., and Vogelstein, B.
(1994) Deletion of p16 and p15 genes in brain tumors.
Cancer Res. 54,6353
-6358.
Jenkins, R.B., Kimmel, D.W., Moertel, C.A., Schultz, C.G., Scheithauer, B.W., Kelly, P.J., and Dewald, G.W. (1989) A cytogenetic study of 53 human gliomas. Cancer Genet. Cytogenet. 39,253 -279.[CrossRef][Web of Science][Medline]
Kallioniemi, A., Kallioniemi, O.P., Sudar, D., Rutovitz, D., Gray,
J.W., Waldman, F., and Pinkel, D. (1992) Comparative genomic
hybridization for molecular cytogenetic analysis of solid tumors.
Science 258,818
-821.
Kallioniemi, O.P., Kallioniemi, A., Piper, J., Isola, J., Waldman, F.M., Gray, J.W., and Pinkel, D. (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10,231 -243.[Web of Science][Medline]
Karhu, R., Siitonen, S., Tanner, M., Keinanen, M., Makipernaa, A., Lehtinen, M., Vilpo, J.A., and Isola, J. (1997) Genetic aberrations in pediatric acute lymphoblastic leukemia by comparative genomic hybridization. Cancer Genet. Cytogenet. 95,123 -129.[CrossRef][Web of Science][Medline]
Kim, D.H., Mohapatra, G., Bollen, A., Waldman, F.M., and Feuerstein, B.G. (1995) Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int. J. Cancer 60,812 -819.[Web of Science][Medline]
Kinzler, K.W., Bigner, S.H., Bigner, D.D., Trent, J.M., Law, M.L.,
O'Brien, S.J., Wong, A.J., and Vogelstein, B. (1987)
Identification of an amplified, highly expressed gene in a human glioma.
Science 236,70
-73.
Kleihues, P., and Cavenee, W.K. (Eds.) (1997) Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer.
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993a) The new WHO classification of brain tumours. Brain Pathol. 3,255 -268.[Web of Science][Medline]
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993b) Histological Typing of Tumours of the Central Nervous System. Second edition. New York: Springer-Verlag.
Kros, J.M., Van Run, P.R., Alers, J.C., Beverloo, H.B., van den Bent, M.J., Avezaat, C.J.J., and Van Dekken, H. (1999) Genetic aberrations in oligodendroglial tumours: An analysis using comparative genomic hybridization (CGH). J. Pathol. 188,282 -288.[CrossRef][Web of Science][Medline]
Larramendy, M.L., Huhta, T., Vettenranta, K., El-Rifai, W., Lundin, J., Pakkala, S., Saarinen-Pihkala, U.M., and Knuutila, S. (1998) Comparative genomic hybridization in childhood acute lymphoblastic leukemia. Leukemia 12,1638 -1644.[CrossRef][Web of Science][Medline]
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I.,
Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella,
B.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M.H., and Parsons, R.
(1997) PTEN, a putative protein tyrosine phosphatase gene mutated
in human brain, breast, and prostate cancer. Science
275,1943
-1947.
Mitelman, F. (Ed.) (1995) ISCN 1995: An International System for Human Cytogenetic Nomenclature (1995). New York: S. Karger.
Mohapatra, G., Kim, D.H., and Feuerstein, B.G. (1995) Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer 13,86 -93.[Web of Science][Medline]
Mohapatra, G., Bollen, A.W., Kim, D.H., Lamborn, K., Moore, D.H., Prados, M.D., and Feuerstein, B.G. (1998) Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer 21,195 -206.[CrossRef][Web of Science][Medline]
Nishizaki, T., Ozaki, S., Harada, K., Ito, H., Arai, H., Beppu, T., and Sasaki, K. (1998) Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer 21,340 -346.[CrossRef][Web of Science][Medline]
Olopade, O.I., Jenkins, R.B., Ransom, D.T., Malik, K., Pomykala,
H., Nobori, T., Cowan, J.M., Rowley, J.D., and Diaz, M.O. (1992)
Molecular analysis of deletions of the short arm of chromosome 9 in human
gliomas. Cancer Res. 52,2523
-2529.
Persson, K., Pandis, N., Mertens, F., Borg, A., Baldetorp, B., Killander, D., and Isola, J. (1999) Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization. Genes Chromosomes Cancer 25,115 -122.[CrossRef][Web of Science][Medline]
Rasheed, B.K., Fuller, G.N., Friedman, A.H., Bigner, D.D., and Bigner, S.H. (1992) Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer 5, 75-82.[Web of Science][Medline]
Rasheed, B.K., McLendon, R.E., Herndon, J.E., Friedman, H.S.,
Friedman, A.H., Bigner, D.D., and Bigner, S.H. (1994) Alterations
of the TP53 gene in human gliomas. Cancer Res.
54,1324
-1330.
Rasheed, B.K., McLendon, R.E., Friedman, H.S., Friedman, A.H., Fuchs, H.E., Bigner, D.D., and Bigner, S.H. (1995) Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 10,2243 -2246.[Web of Science][Medline]
Rasheed, B.K., Stenzel, T.T., McLendon, R.E., Parsons, R.,
Friedman, A.H., Friedman, H.S., Bigner, D.D., and Bigner, S.H.
(1997) PTEN gene mutations are seen in high-grade but not in
low-grade gliomas. Cancer Res.
57,4187
-4190.
Reifenberger, G., Reifenberger, J., Ichimura, K., Meltzer, P.S.,
and Collins, V.P. (1994) Amplification of multiple genes from
chromosomal region 12q13–14 in human malignant gliomas: Preliminary
mapping of the amplicons shows preferential involvement of CDK4, SAS, and
MDM2. Cancer Res. 54,4299
-4303.
Schlegel, J., Scherthan, H., Arens, N., Stumm, G., and Kiessling, M. (1996) Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J. Neuropathol. Exp. Neurol. 55,81 -87.[Web of Science][Medline]
Schmidt, E.E., Ichimura, K., Reifenberger, G., and Collins, V.P.
(1994) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification
occurs in the majority of glioblastomas. Cancer Res.
54,6321
-6324.
Schrock, E., Thiel, G., Lozanova, T., du Manoir, S., Meffert, M.C., Jauch, A., Speicher, M.R., Nurnberg, P., Vogel, S., and Janisch, W. (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol. 144,1203 -1218.[Abstract]
Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D.H., and Tavtigian, S.V. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15,356 -362.[CrossRef][Web of Science][Medline]
Trent, J., Meltzer, P., Rosenblum, M., Harsh, G., Kinzler, K.,
Mashal, R., Feinberg, A., and Vogelstein, B. (1986) Evidence for
rearrangement, amplification, and expression of c-myc in a human glioblastoma.
Proc. Natl. Acad. Sci. U.S.A.,
83,470
-473.
Ueki, K., Rubio, M.P., Ramesh, V., Correa, K.M., Rutter, J.L., von
Deimling, A., Buckler, A.J., Gusella, J.F., and Louis, D.N.
(1994) MTS1/CDKN2 gene mutations are rare in primary human
astrocytomas with allelic loss of chromosome 9p. Hum. Mol.
Genet. 3,1841
-1845.
Venkatraj, V.S., Begemann, M., Sobrino, A., Bruce, J.N., Weinstein, I.B., and Warburton, D. (1998) Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization. J. Neurooncol. 36,141 -148.[CrossRef][Medline]
Walker, D.G., Duan, W., Popovic, E.A., Kaye, A.H., Tomlinson, F.H.,
and Lavin, M. (1995) Homozygous deletions of the multiple tumor
suppressor gene 1 in the progression of human astrocytomas. Cancer
Res. 55,20
-23.
Wang, S.I., Puc, J., Li, J., Bruce, J.N., Cairns, P., Sidransky,
D., and Parsons, R. (1997) Somatic mutations of PTEN in
glioblastoma multiforme. Cancer Res.
57,4183
-4186.
Weber, R.G., Sabel, M., Reifenberger, J., Sommer, C., Oberstrass, J., Reifenberger, G., Kiessling, M., and Cremer, T. (1996a) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13,983 -994.[Web of Science][Medline]
Weber, R.G., Sommer, C., Albert, F.K., Kiessling, M., and Cremer, T. (1996b) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab. Invest. 74,108 -119.[Web of Science][Medline]
Wilkens, L., Tchinda, J., Nolte, M., Werner, M., and Georgii, A. (1998) Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). Hum. Pathol. 29,833 -839.[CrossRef][Web of Science][Medline]
Wilkens, L., Burkhardt, D., Tchinda, J., Busche, G., Werner, M., Nolte, M., Ganser, A., and Georgii, A. (1999) Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization. Diagn. Mol. Pathol. 8,47 -53.[CrossRef][Web of Science][Medline]
Wiltshire, R.N., Duray, P., Bittner, M.L., Visakorpi, T., Meltzer,
P.S., Tuthill, R.J., Liotta, L.A., and Trent, J.M. (1995) Direct
visualization of the clonal progression of primary cutaneous melanoma:
Application of tissue microdissection and comparative genomic hybridization.
Cancer Res. 55,3954
-3957.
Zitzelsberger, H., Lehmann, L., Werner, M., and Bauchinger, M. (1997) Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem. Cell Biol. 108,403 -417.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  V Martin, L Mazzucchelli, and M Frattini An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology J. Clin. Pathol., April 1, 2009; 62(4): 314 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kuga, M. Mizoguchi, Y. Guan, N. Hata, K. Yoshimoto, T. Shono, S. O. Suzuki, Y. Kukita, T. Tahira, S. Nagata, et al. Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues Neuro-oncol, January 1, 2008; 10(6): 995 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Zhou, K. R. Hess, L. Liu, Mark. E. Linskey, and W.K. A. Yung Modeling prognosis for patients with malignant astrocytic gliomas: Quantifying the expression of multiple genetic markers and clinical variables Neuro-oncol, October 1, 2005; 7(4): 485 - 494. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. Nigro, A. Misra, L. Zhang, I. Smirnov, H. Colman, C. Griffin, N. Ozburn, M. Chen, E. Pan, D. Koul, et al. Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma Cancer Res., March 1, 2005; 65(5): 1678 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Wiltshire, J. E. Herndon II, A. Lloyd, H. S. Friedman, D. D. Bigner, S. H. Bigner, and R. E. McLendon Comparative Genomic Hybridization Analysis of Astrocytomas: Prognostic and Diagnostic Implications J. Mol. Diagn., August 1, 2004; 6(3): 166 - 179. [Abstract] [Full Text]
|
|
|
|
|
|
E. C. Burton, K. R. Lamborn, B. G. Feuerstein, M. Prados, J. Scott, P. Forsyth, S. Passe, R. B. Jenkins, and K. D. Aldape Genetic Aberrations Defined by Comparative Genomic Hybridization Distinguish Long-Term from Typical Survivors of Glioblastoma Cancer Res., November 1, 2002; 62(21): 6205 - 6210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Bernard and C. T. Wittwer Real-Time PCR Technology for Cancer Diagnostics Clin. Chem., August 1, 2002; 48(8): 1178 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Aldosari, R. N. Wiltshire, A. Dutra, E. Schrock, R. E. McLendon, H. S. Friedman, D. D. Bigner, and S. H. Bigner Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft Neuro-oncol, April 1, 2002; 4(2): 75 - 85. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
